‘Shocking’ MHRA Performance & Poor Data Transparency Blamed For UK’s Clinical Trial Crisis

While the UK’s drug regulator, the MHRA, has “pulled its socks up massively” in recent months, its poor performance was highlighted as a top cause of the UK’s faltering clinical trials ecosystem by a former health minister.